M
ycobacterium bovis is the primary causative agent of bovine tuberculosis (TB) in cattle. M. bovis is a member of the Mycobacterium tuberculosis complex (MTC), which also includes M. tuberculosis, M. caprae, M. microti, M. africanum, M. canettii, and M. pinnipedii (1) . MTC species are similar to one another in their ability to cause tuberculosis infections; however, their host range and their virulence between hosts vary. M. bovis has the largest host range of the MTC species, infecting wildlife as well as alternative and domestic livestock, which makes it difficult to control (2) . In many developed countries, cattle herds are monitored for bovine tuberculosis using slaughterhouse surveillance and antemortem testing. Antemortem testing is primarily based upon measures of cell-mediated immunity, such as the tuberculin skin test (e.g., caudal fold test [CFT] or single intradermal comparative cervical test [SICCT] ) and gamma interferon (IFN-␥) release assays (e.g., Bovigam; Prionics AG, Schlieren, Switzerland) (3) . In regions where annual skin testing is largely absent, such as tuberculosis-free states within the United States, most infected cattle go unnoticed until a lesioned animal is detected by slaughterhouse surveillance (4) . After infection is detected, the movement history is investigated to determine other contact herds and the origin of infection (3) . Affected herds may be depopulated, or a test and slaughter approach may be applied using skin tests and/or the IFN-␥ release assay. Additionally, emerging serologic tests (i.e., antibody-based tests) are being evaluated for use in tuberculosis control programs. Although these tests are relatively accurate, improvement of antemortem diagnostic methods is needed.
The IFN-␥ release assay was developed to aid in the diagnosis of bovine tuberculosis and is currently used mainly as a supplemental assay to the skin test in most TB eradication/control programs. IFN-␥ is produced in high quantities in vitro and is not readily consumed during short-term culture (5, 6) , making it a good biomarker for use in tuberculosis diagnostic tests (7) . The standard use of the IFN-␥ assay is performed by stimulating whole blood for 16 to 24 h with M. bovis purified protein derivative (PPDb), M. avium PPD (PPDa), medium alone (no stimulation), and a mitogen control for cell viability (6) . IFN-␥ produced within the stimulated samples is then measured by an enzyme-linked immunosorbent assay (ELISA). Infection status is determined by comparing differential amounts of IFN-␥ produced in response to PPDb and PPDa stimulation.
Compared to the skin test, the IFN-␥ assay has increased sensitivity and a slightly lower specificity, requires a single visit to the farm, and prevents observational variability associated with assessing skin test reactions (3, 8, 9) . With the use of PPDs, the sensitivity and specificity of the IFN-␥ assay are estimated at 73 to 100% and 87.7 to 99.2%, respectively (4, 9) . Implementing TBspecific antigens into the IFN-␥ assay may increase the accuracy of the test (10) and provide differentiation of infected from vaccinated animals (DIVA) (11) . Early secretory antigen target 6 (ESAT-6) and culture filtrate protein 10 (CFP10) are TB-specific proteins that have been extensively studied for use in the detection of bovine tuberculosis (10, 12, 13, 14) . When used as recombinant proteins or peptide cocktails, ESAT-6 and CFP10 are known to elicit immune responses, both in vitro (13, 14, 15) and in vivo (16) , in M. bovis-infected cattle. Aagaard and colleagues (10) demonstrated decreased sensitivity (86% versus 97%) yet increased specificity (99% versus 94%) when comparing an ESAT-6 and CFP10 peptide cocktail to PPDs as antigens for use in the IFN-␥ assay. This increased specificity elicited by the ESAT-6 and CFP10 peptide cocktail is promising; however, more research is needed to determine methods to increase sensitivity (17) . For instance, use of ESAT-6 and CFP10 in combination with Rv3615 in the IFN-␥ assay has been shown to increase sensitivity without loss of specificity (18) .
Objectives of the current study were to compare IFN-␥ responses elicited by Commonwealth Serum Laboratories (CSL) and Lelystad PPDs (Prionics AG) and two MTC-specific peptide cocktails, as well as liquid and lyophilized preparations. Studies were performed using samples from three groups of cattle, each experimentally infected with a different strain of M. bovis, as well as samples from a tuberculosis-affected herd (i.e., natural infection) within the United States. Strains for experimental infection included M. bovis Ravenel (a laboratory-adapted strain attenuated in cattle), M. bovis 95-1315 (a white-tailed deer isolate), and M. bovis 10-7428 (a cattle field isolate from a Colorado dairy herd). PPDs and peptide cocktails were also used to compare a secondgeneration Bovigam kit to the currently available kit.
MATERIALS AND METHODS
Calves, aerosol challenge, and necropsy. For the first study, 15 9-monthold Holstein castrated male cattle were housed in a biosafety level 3 (BSL-3) containment facility in Ames, IA, at the National Animal Disease Center (NADC). All animal care and use procedures were reviewed and approved by the NADC Animal Care and Use Committee. CFU, n ϭ 8), and a noninfected control group (n ϭ 7). Strains were prepared using standard procedures (19) in Middlebrook 7H9 liquid medium (Becton Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-albumin-dextrose-catalase complex (OADC) plus 0.05% Tween 80 (0.5% glycerol was included for strain Ravenel only). Enumeration of M. bovis challenge inocula, necropsy procedures (ϳ3.5 months after challenges), gross and microscopic assessment of lesions, and mycobacterial culture of M. bovis from tissues were performed as described previously (15, 20) . The inoculation of each of the strains in both studies was via aerosol as described previously (20) . Additionally, whole-blood samples were obtained from animals from a TB-affected herd in Colorado. Animals were categorized as infected based on positive culture of M. bovis (infected, n ϭ 56). Antigens. PPDs and peptide cocktails were provided by Prionics AG (Schlieren, Switzerland) in liquid and lyophilized forms. RPMI 1640 medium (Life Technologies, Grand Island, NY) was used as a negative control and pokeweed mitogen (PWM; 5 g/ml; Sigma-Aldrich, St. Louis, MO) was included as a positive control of cell viability. The two peptide cocktails consisted of ESAT-6 and CFP10 (PC-EC; Prionics AG) and ESAT-6, CFP10, Rv3615, and three other mycobacterium antigens (PC-HP; Prionics AG). Aliquots of liquid preparations of PC-HP and PC-EC were kept frozen at Ϫ20°C until the day of use. PC-HP and PC-EC were used according to the manufacturer's instructions. CSL PPDa and CSL PPDb were used at 20 g/ml concentrations and Lelystad PPDa and Lelystad PPDb were used at 200 IU and 250 IU, respectively, as optimized and suggested by the manufacturers. All antigens were diluted in RPMI 1640 medium.
Whole-blood stimulation. For the first study, whole blood was collected in sodium-heparinized tubes 2 weeks prior to aerosol challenge and at 3, 6, 8, 11 , and 12 weeks postchallenge. On the day of blood collection, 250 l of blood was added to 96-well plates for each animal. Twenty-five microliters of each antigen (PPDs and peptide cocktails) and controls (e.g., RPMI 1640 and PWM) was added in duplicate to selected wells. Plates were incubated at 39°C with 5% CO 2 for 18 to 22 h. Plasma samples were harvested from each stimulation for each animal and placed in individual microtubes (VWR Scientific, Radnor, PA) and stored at Ϫ80°C until analyzed for IFN-␥ concentrations via the Bovigam assay. For the second study, blood was collected at 2 weeks prechallenge as well as 2, 3, 4, 6, 8, and 12 weeks postchallenge. Whole-blood stimulation procedures were the same as those used in the first study.
IFN-␥ detection. In the first study, IFN-␥ assays were performed using the first-generation Bovigam kit (Prionics AG). In the second study, first-and second-generation Bovigam kits were used. All IFN-␥ release assays were performed according to kit procedures. Each plasma sample and standard was tested in duplicate. Recombinant bovine IFN-␥ (Thermo Scientific, Rockford, IL) was used as a standard at 25 ng/ml, 12.5 ng/ml, 6.25 ng/ml, 5 ng/ml, 2.5 ng/ml, 1.5 ng/ml, 1.25 ng/ml, 0.625 ng/ml, and 0.3125 ng/ml, along with the positive and negative controls supplied by the manufacturer. Samples were read at a wavelength of 450 nm using a SPECTRAmax 340 microplate reader (Molecular Devices, Sunnyvale, CA) and analyzed using SOFTmax PRO software (Molecular Devices, Sunnyvale, CA) to calculate optical density (OD). Responses to the negative control (RPMI 1640) for each animal were subtracted from all antigen and mitogen responses. Results were considered positive if responses to PPDb (OD at 450 mm [OD 450 ]) minus responses to PPDa (OD 450 ) were Ͼ0.1 OD.
Tuberculin skin test procedures. Skin tests were performed as specified in the circular on uniform methods and rules for the eradication of bovine tuberculosis in the United States (Animal and Plant Health Inspection Service [APHIS] circular 91-45-011) (21) . At 10 weeks (study 1) or 12 weeks (study 2) postchallenge, skin thickness was measured with calipers immediately before intradermal injection of PPDa and PPDb (National Veterinary Services Laboratories, Ames, IA). The skin thickness was measured again after 72 h. The skin test was performed in the midcervical region (i.e., comparative cervical test). Responses were recorded on a scattergram for the interpretation of comparative cervical tests to determine the outcome of the tests (i.e., negative, suspect, or reactor).
Cattle pathogenesis studies: bacterial recovery and assessment of lesions. All calves were euthanized by intravenous administration of sodium pentobarbital ϳ3.5 months after challenge. Tissues were observed for gross lesions and collected and processed for microscopic analysis and isolation of M. bovis. Tissues collected included palatine tonsil, lung, and liver and mandibular, parotid, medial retropharyngeal, mediastinal, tracheobronchial, hepatic, and mesenteric lymph nodes. Lymph nodes were sectioned at 0.5-cm intervals and examined. Each lung lobe was sectioned at 0.5-cm to 1.0-cm intervals and examined separately.
Tissues collected for microscopic analysis were fixed by immersion in 10% neutral buffered formalin. For microscopic examination, formalinfixed tissues were processed by standard paraffin-embedment techniques, cut in 5-m sections, and stained with hematoxylin and eosin. Adjacent sections from samples containing caseonecrotic granulomata suggestive of tuberculosis were excised and stained by the Ziehl-Neelsen technique for identification of acid-fast bacteria.
M. bovis isolates were obtained from cattle tissues as described previously (22) . Briefly, tissues were macerated in phenol red nutrient broth using a blender (Oster, Shelton, CT). Homogenates were decontaminated with NaOH and then neutralized with HCl. Samples were centrifuged, supernatants were removed, and pellets were used to inoculate the media (Middlebrook 7H10, 7H11, and 7H11 with antibiotics). Plates were incubated at 37°C and examined weekly for growth.
Statistics. Results were analyzed using Prism software (GraphPad, La Jolla, CA). Optical densities were converted to ng/ml using the standard curve calculated from standards observed on each plate for each date. Data were analyzed using repeated measures analysis of variances with the Bonferroni multiple comparisons test and the Mann-Whitney t test.
RESULTS

Experimental infection.
Ten to 12 weeks after challenge, all cattle receiving M. bovis, regardless of strain (i.e., Ravenel, 95-1315, or 10-7428), were classified as reactors based upon standard interpretation of the comparative cervical skin test. Delayed-type hypersensitivity responses were not detected (i.e., classified as negative) with any of the animals within the noninfected control group. Upon necropsy, only one M. bovis Ravenel-inoculated calf had a single small granuloma in the left caudal lung lobe. (Fig. 1b) . Significant differences were not detected between liquid and lyophilized products for any antigens within each treatment group (Fig. 1b) . As utilized for official use of the Bovigam test kit, responses to PPDb minus PPDa did not differ (P Ͼ 0.05) for liquid and lyophilized antigen preparations at any time point within each treatment group (Fig. 1c) .
IFN-␥ responses to PPDa exceeded (P Ͻ 0.01) respective responses to PPDb for control animals (Fig. 1b) , demonstrating prior sensitization to nontuberculous mycobacteria (NTM). Responses to MTC-specific antigens (PC-HP and PC-EC) were not detectable prior to challenge (Fig. 2a) , and subtraction of PPDa responses from PPDb (PPDb minus PPDa) resulted in values of Ͻ0.1 ⌬OD 450 (i.e., negative) for all animals prior to challenge (Fig.  1c) . Thus, responses to PPDb detected prior to challenge in all groups (Fig. 1a) were likely due to cross-reactive responses elicited by NTM.
Evaluation of peptide cocktails for the detection of bovine tuberculosis. As early as 3 weeks after challenge, responses to PC-HP and PC-EC by M. bovis Ravenel-and M. bovis 95-1315-inoculated animals exceeded (P Ͻ 0.05) respective prechallenge responses and responses by control animals (Fig. 2a) . When all time points were pooled, there was no difference (P Ͼ 0.05) between responses to PC-HP and PC-EC within treatment groups (Fig. 2b) . Similar responses were detected in the second study using M. bovis 95-1315-and M. bovis 10-7428-challenged animals, and responses to PC-HP and PC-EC did not differ within treatment groups (see Fig. S1 in the supplemental material). These findings demonstrate that responses to PC-HP and PC-EC are similar for the early detection of M. bovis infection in cattle. (Fig. 3a) . Similarly, responses to Lelystad PPDb exceeded (P Ͻ 0.05) that of CSL PPDb in control animals when pooled (Fig. 3a) .
Comparison of IFN-␥ responses to Lelystad and CSL PPDs in
Experimental infection of cattle with M. bovis results in robust IFN-␥ responses to both PPDb and PPDa (due to cross-reactivity of antigens) that are often at the maximum detection limit of the assay, thereby limiting the comparisons of PPD potencies and diagnostic potential. Thus, several dilutions of stimulated plasma were evaluated at selected time points to further evaluate the kinetics of the response and potency comparisons of the two PPDs (Table 1 and Fig. 4 ). When plasma from experimentally infected animals was diluted, it was determined that the majority of responses after challenge to PPDa were lower than the response to PPDb, giving a difference greater than 0.1 OD 450 , indicating a positive test result (Table 1 and Fig. 4) . For diluted plasma samples, responses to Lelystad PPDb minus PPDa exceeded (P Ͻ 0.05) respective responses to CSL PPDb minus PPDa (Fig. 4) . In gen- eral, diluting the plasma enabled improved accuracy for the detection of M. bovis infection in experimentally infected animals in addition to reducing the false-positive test results within the control group.
To further compare CSL and Lelystad PPDs, samples were obtained from a tuberculosis-affected dairy herd (Colorado, n ϭ 56) in the United States. All animals were deemed M. bovis infected via mycobacterial culture. In contrast to experimental infection studies, in which samples were placed in culture with antigen within 2 h of blood collection, samples from naturally infected animals were shipped overnight and set up within 20 h of blood collection. Responses to Lelystad PPDs exceeded (P Ͻ 0.01) those to CSL PPDs, including PPDb minus PPDa (Fig. 5) .
Performances of second-generation Bovigam kits compared to those of the currently licensed kits. The currently licensed Bovigam kits (B1G) and second-generation Bovigam kits (B2G) were compared using experimentally infected animals (Fig. 6) . IFN-␥ responses were not different (P Ͼ 0.05) between the two kits when time points were pooled (Fig. 6a) . B2G kits were just as effective in the differentiation of control and infected groups when calculations of PPDb minus PPDa were performed throughout the course of the study (Fig. 6b, c, and d) .
DISCUSSION
IFN-␥ is a reliable biomarker for use in the detection of M. bovis
infection. With the current use of the Bovigam assay, antigens are provided within the kit as a liquid preparation. In this study, lyophilization had no effect on antigen performance. Responses were detected as early as 3 weeks postchallenge using both liquid and lyophilized antigen preparations. These findings indicate that a Animals were considered positive when PPDa responses were subtracted from PPDb responses and the difference in OD 450 was Ͼ0.1. b Some animals within the experimentally infected groups were still at the maximum limit of detection, making it difficult to detect differences in responses to PPDb and PPDa. lyophilized preparations may be implemented into the IFN-␥ assay without loss in potency, thereby increasing the shelf life of the test kits. Additional TB-specific antigens are needed to further increase the accuracy of the IFN-␥ release assay. Interestingly, although both PC-HP and PC-EC were not significantly different in the responses they elicited in infected animals throughout the study, responses to PC-HP were slightly higher than responses to PC-EC, which is consistent with findings by Sidders and colleagues (18) . In experimentally infected animals, responses to PC-HP and PC-EC were detectable as early as 3 weeks postchallenge. PC-HP and PC-EC are commercially available products that may prove useful as antigens for bovine tuberculosis test kits, both for research and diagnostic purposes. PPDs from differing manufacturers and lots are known to vary in potency (8) . Commonwealth Serum Laboratories (CSL) has been the producer of PPDs for the Bovigam assay since the test was first approved for use in the United States. Due to manufacturing and marketing reasons, it is possible that CSL PPDs will not be available in the near future. Thus, it is critical to validate use of different PPDs within bovine tuberculosis diagnostic tests. Whipple and colleagues performed direct comparisons between CSL PPDs and PPDs prepared in the United States (USDA, APHIS, National Veterinary Services Laboratory) using the CFT and IFN-␥ assay and found that the final interpretation of the test (i.e., positive and negative animals identified by each PPD) was usually the same (25) . However, U.S. PPDs elicited a higher response (25) . Recently, Lelystad PPDs (Prionics AG) were adopted for use in the skin test and Bovigam assay in the United Kingdom, Republic of Ireland, and various other European Union countries. Downs and colleagues reviewed data from field surveillance results of the single intradermal comparative cervical test (SICCT) using Lelystad and Weybridge (Central Veterinary Laboratory) PPDs in England, Scotland, and Wales from 2005 to 2009 (26) . Due to financial reasons, Defra halted production of tuberculin at ever, direct comparisons to CSL PPDs have not been performed. In the present study, IFN-␥ responses to Lelystad and CSL PPDs largely did not differ in undiluted samples from experimentally infected cattle ( Fig. 3 ; also see Fig. S2 in the supplemental material). However, use of diluted sera (1:4) revealed greater differentiation of PPDb from PPDa responses with Lelystad PPDs versus CSL PPDs (i.e., PPDb minus PPDa) (Fig. 4) elicited after experimental M. bovis infection. With samples from a tuberculosis-affected herd, responses to Lelystad PPDs exceeded respective responses to CSL PPDs.
Experimental infection of cattle resulted in IFN-␥ responses to both PPDb and PPDa that reached the maximum limit of detection, resulting in responses to PPDb minus PPDa of Ͻ0.1 ⌬OD (i.e., negative), even though these animals were clearly infected as evidenced by robust IFN-␥ responses to MTC peptide cocktails, delayed-type hypersensitivity responses to PPDb exceeding those to PPDa, and isolation of M. bovis from tissues at necropsy. Thus, differences between control and infected animals were not detectable using the analysis of PPDb minus PPDa with undiluted stimulated plasma. To address this issue, dilutions of plasma were evaluated to ascertain IFN-␥ concentrations detectable within assay limits. After dilution (1:4), samples from infected animals had responses to PPDb that exceeded (P Ͻ 0.05) respective responses to PPDa, thus enabling an accurate diagnosis using calculations of PPDb minus PPDa. Dilution of plasma may be incorporated as a means to determine differences in IFN-␥ responses to PPDb and PPDa. This may be particularly useful in regions where detection of bovine tuberculosis is hindered by high levels of exposure to NTM that elicit cross-reactive responses to PPDs. Additionally, evaluation of diluted samples may be useful when evaluating responses by animals with very robust responses, as seen with experimentally infected animals in this study. Indeed, use of diluted plasma with samples from experimentally infected cattle revealed responses to Lelystad PPDs exceeding those to CSL PPDs. These findings suggest that the use of Lelystad PPDs will provide greater diagnostic sensitivity than CSL PPDs.
In the current study, three strains of M. bovis were used to compare IFN-␥ responses to PPDs and peptide cocktails elicited after experimental infection. With the use of the IFN-␥ release assay, robust responses were detected using PPDs from the two different manufacturers as well as PC-HP and PC-EC. Strains examined were M. bovis 95-1315 (white-tailed deer field isolate), M. bovis Ravenel (laboratory-adapted strain), and M. bovis 10-7428 (cattle field isolate from a Colorado dairy). M. bovis strain 95-1315 has been used previously in experimental infection of cattle and has been shown to elicit robust immune responses as well as granulomatous lesions at necropsy (15) . M. bovis strain Ravenel was isolated in the early 1900s, and although it is virulent in mice (28), rabbits (28, 29) , and guinea pigs (13, 28, 30) , it does not lead to progressive disease in cattle (W. R. Waters and M. V. Palmer, unpublished observations). M. bovis strain 10-7428 was isolated from a Holstein cow in a dairy herd in Colorado. This strain is speculated to be highly virulent given the high rate of progression of disease in this herd (Tolani Francisco, personal communication). In the first study, all M. bovis 95-1315 animals had granulomatous lesions, whereas only one M. bovis Ravenel animal had a small tuberculous lesion. In the second study, all animals in the M. bovis 95-1315 and M. bovis 10-7428 groups showed lesions upon necropsy as well as robust skin test responses. Thus, evaluation of IFN-␥ responses to various antigen preparations in the present study were evaluated with samples from animals inoculated with 3 strains with varied virulence levels.
PPDs and peptide cocktails were also used for comparison of two generations of Bovigam kits. The second-generation kit requires a decreased number of repeated washes and combines the conjugate and chromogen into one solution; however, stimulation and incubation times within the test did not change. Although the new kit did not decrease the performance time, it did reduce the time for work labor. Present findings support the use of the second-generation Bovigam kit (B2G) for replacement of the current kit (B1G) in the detection of bovine tuberculosis.
In conclusion, lyophilized PPDs, PC-EC, and PC-HP are effective replacements for liquid antigens for use in the Bovigam assay. PC-HP and PC-EC are reliable biomarkers of bovine tuberculosis, and second-generation Bovigam kits perform similarly to firstgeneration kits. The present findings, while not definitive, are encouraging for replacement of CSL PPDs with Lelystad PPDs for use in the Bovigam assay to detect bovine tuberculosis in the United States. These findings, along with future evaluation of naturally infected animals, have the potential to increase the accuracy of current antemortem diagnostic methods in the detection of bovine tuberculosis.
